Article Details

Stelis Biopharma's CDMO partner receives USFDA approval for a key ANDA

Retrieved on: 2022-12-28 09:16:30

Tags for this article:

Click the tags to see associated articles and topics

Stelis Biopharma's CDMO partner receives USFDA approval for a key ANDA. View article details on HISWAI: https://www.business-standard.com/article/news-cm/stelis-biopharma-s-cdmo-partner-receives-usfda-approval-for-a-key-anda-122122800579_1.html

Excerpt

Stelis Biopharma, the biologics arm of Strides Pharma Science announced ... The filing for the product was done from Stelis Biopharma's flagship ...

Article found on: www.business-standard.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up